v3.26.1
Financial Instruments - Additional Information (Details)
$ / shares in Units, $ in Millions
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
USD ($)
Jun. 30, 2025
USD ($)
Jun. 30, 2026
USD ($)
$ / shares
shares
Jun. 30, 2025
USD ($)
Dec. 31, 2025
USD ($)
Mar. 31, 2026
USD ($)
Mar. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Derivative [Line Items]                
Debt securities interest income     $ 130   $ 105      
Net loss on equity method investment $ 22 $ 24 43 $ 47        
Unrealized gain (loss) 1,250 682 189 (339)        
Klaviyo, Inc.                
Derivative [Line Items]                
Unrealized gain (loss) (11) 14 (65) (72)        
Equity Securities Without Readily Determinable Fair Value                
Derivative [Line Items]                
Equity and Other Investments $ 1,555 $ 988 $ 1,555 $ 988 $ 963 $ 970 $ 709 $ 717
Call Option | Klaviyo, Inc.                
Derivative [Line Items]                
Option to purchase series B common shares | shares     15,743,174          
Exercise price (in dollars per share) | $ / shares     $ 88.93          
Discount for Lack of Marketability | Klaviyo, Inc.                
Derivative [Line Items]                
Derivative asset, measurement input 0.19   0.19   0.21      
Fair value $ 9   $ 9   $ 75      
Foreign Exchange Forward                
Derivative [Line Items]                
Foreign exchange forward contracts, notional value 777   777   $ 702      
Level 3 | Fair Value, Nonrecurring                
Derivative [Line Items]                
Equity and Other Investments $ 1,376   $ 1,376